COVID─19 pandemic has accelerated the pharma industry’s adoption of digital technologies. The industry not just in India but globally too is rapidly recognizing the potential of mobile apps and social media platforms to connect with healthcare practitioners (HCPs), said Sharad Tyagi, managing director, Boehringer Ingelheim, India.
